Insiders sold $1.76M and bought nothing on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. Director J. Anthony Ware sold $1.76M on Sep 2, 71% of their stake, outside a plan. No executive or director has bought shares on the open market in the last two years.
Get an email when TRAX's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Sep 2 | J. Anthony Ware Director | SoldNo plan | 39,265 | $44.78 | $1.76M | 71% | Form 4 |
| Apr 20 | Ecor1 Capital, LLC Large holder | SoldNo plan | 4,705,575 | $13.81 | $65M | New | Form 4 |
- Sep 2No planJ. Anthony WareDirector · sold 39,265 at $44.78$1.76M71% of stake
- Apr 20No planEcor1 Capital, LLCLarge holder · sold 4,705,575 at $13.81$65MNew position
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biotechnology · Pick stocks to compare with TRAX
Held by ETFs
TRAX is in 37 US ETFs. The largest of them, with TRAX's weight in each:
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing TRAX
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.